Get the Stockscreener App
1.305
5.10%
0.325
Marpai Inc stock is traded at $1.305, with a volume of 21,722.
It is up +5.10% in the last 24 hours and down -70.73% over the past month.
See More
Previous Close:
$0.98
Open:
$1.16
24h Volume:
21,722
Relative Volume:
70.91
Market Cap:
$N/A
Revenue:
$37.16M
Net Income/Loss:
$-28.75M
P/E Ratio:
-0.3049
EPS:
-4.28
Net Cash Flow:
$-15.75M
1W Performance:
+5.10%
1M Performance:
-70.73%
6M Performance:
-65.40%
1Y Performance:
+3.84%
1-Day Range:
$1.16
$1.32
1-Week Range:
$1.16
$1.32
52-Week Range:
$1.16
$1.32
Marpai Inc Stock (MRAI) Company Profile
Compare MRAI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRAI
Marpai Inc
|
1.305 | 0 | 37.16M | -28.75M | -15.75M | -4.28 |
|
UNH
Unitedhealth Group Inc
|
239.24 | 215.69B | 422.82B | 21.30B | 25.27B | 23.08 |
|
CVS
Cvs Health Corp
|
61.71 | 79.23B | 386.64B | 4.53B | 4.78B | 3.58 |
|
CI
Cigna Group
|
264.23 | 70.00B | 261.22B | 5.02B | 3.94B | 18.32 |
|
ELV
Elevance Health Inc
|
277.58 | 61.85B | 189.25B | 5.36B | 5.34B | 23.50 |
|
HUM
Humana Inc
|
245.77 | 29.74B | 117.76B | 1.21B | 2.39B | 9.95 |
Marpai Inc Stock (MRAI) Latest News
Insider Buying and the Marpai Catalyst: A Deep Dive into CEO Confidence and Market Potential - AInvest
Marpai CEO Makes Bold Move with Major Stock Purchase! - TipRanks
MARPAIRX REVOLUTIONIZES PHARMACY BENEFITS WITH UNPRECEDENTED TRANSPARENCY AND SAVINGS - Eastern Progress
CEO Makes Bold Move with Major Stock Purchase in Marpai! - TipRanks
Marpai Enters Securities Purchase Agreement July 2025 - TipRanks
Marpai (NASDAQ:MRAI) Shares Down 3.6% – What’s Next? - Defense World
Marpai (NASDAQ:MRAI) Trading Up 0.7% – Here’s Why - Defense World
Marpai targets cash flow positivity in 2025 with cost reductions and leadership changes - MSN
Marpai, Inc. (OTC:MRAI) Q1 2025 Earnings Call Transcript - Insider Monkey
Marpai, Inc. Reports Q1 2025 Financial Results - TipRanks
Marpai, Inc. Earnings Call Highlights Mixed Results - TipRanks
Earnings call transcript: Marpai posts improved Q1 2025 results amid cost cuts - Investing.com
MARPAI revenue down 27% to USD 5.4M in Q1 2025 - Medical Buyer
MARPAI REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS - PR Newswire
Marpai Appoints Dallas Scrip as New COO - TipRanks
Marpai appoints new COO to accelerate growth By Investing.com - Investing.com India
Marpai appoints new COO to accelerate growth - Investing.com Australia
MARPAI HIRES DALLAS SCRIP AS CHIEF OPERATING OFFICER - PR Newswire
MARPAI TO HOST WEBCAST ON MAY 15, 2025 TO DISCUSS FIRST QUARTER 2025 FINANCIAL RESULTS - Nasdaq
Marpai Confirms Revenue Guidance For Q2 2023 Of $9.5 Million To $9.8 Million - Barchart.com
Health In Tech Announces Innovative Collaboration with MARPAI and Vitable DPC to Offer Competitive Quotes in Enhanced Self-Funded Solutions (PR Newswire) - Aktiellt
Marpai, Inc. to Present at the Planet MicroCap Showcase Las Vegas - Longview News-Journal
MARPAI, INC. REPORTS SECOND QUARTER 2023 RESULTS - Seeking Alpha
Marpai, Inc. (NASDAQ:MRAI) Q4 2024 Earnings Call Transcript - Insider Monkey
Marpai, Inc. Earnings Call: Mixed Sentiments and Strategic Focus - TipRanks
Marpai Inc (MRAI) Q4 2024 Earnings Call Highlights: Navigating Financial Challenges with ... By GuruFocus - Investing.com Canada
Marpai, Inc. Reports Improved Financial Performance - TipRanks
Marpai targets profitability in 2025 with new initiatives and strategic partnerships - MSN
Marpai Inc. (MRAI) reports earnings - Quartz
MARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS - Quantisnow
MARPAI TO HOST WEBCAST ON MARCH 27, 2025 TO DISCUSS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS - The Malaysian Reserve
MARPAI ACCELERATES HEALTHCARE TRANSFORMATION WITH EMPARA COLLABORATION, LAUNCHING UNIFIED HEALTH ENGAGEMENT PLATFORM - MarketScreener
Marpai reduces debt by $3 million in new agreement - Investing.com
Health In Tech Announces Innovative Collaboration with MARPAI and Vitable DPC to Offer Competitive Quotes in Enhanced Self-Funded Solutions - Nasdaq
MARPAI ANNOUNCES SECOND TRANCHE OF NON-DILUTIVE GROWTH FUNDING WITH UP TO $5 MILLION FROM JGB - PR Newswire
Marpai president John Paul Powers buys $11,299 in stock - Investing.com
MARPAI ANNOUNCES PRICING OF $700,000 PRIVATE PLACEMENT - PR Newswire
MARPAI ANNOUNCES GENERAL UPDATES FOR Q4 - PR Newswire
MARPAI REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS - PR Newswire
Marpai CEO acquires $650k in company stock amidst market moves - Investing.com
MARPAI ANNOUNCES NEW "OFF CYCLE" CLIENT CONTRACT - PR Newswire
MARPAI TO HOST WEBCAST ON AUGUST 8, 2024 TO DISCUSS SECOND QUARTER 2024 FINANCIAL RESULTS - Yahoo Finance
MARPAI PRESIDENT JOHN POWERS TABBED TO SPEAK AT 3 ELITE HEALTHCARE CONFERENCES - Yahoo Finance
Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc.; NextPlay - EIN News
Delisting of Securities of RiskOn International, Inc.; Graphjet Technology; Agile Therapeutics, Inc.; NextPlay Technologies, Inc.; Relativity Acquisition Corp.; iSun, Inc.; Ace Global Business Acquisition Limited; and Marpai, Inc. from The Nasdaq Stock Market - StockTitan
OTC Markets Group Welcomes Marpai, Inc. to OTCQX - Yahoo Finance
Marpai stock sinks 42% premarket on Nasdaq delisting - MSN
Why Is Marpai (MRAI) Stock Down 41% Today? - InvestorPlace
MARPAI ANNOUNCES WITHDRAWAL FROM NASDAQ HEARINGS PROCESS AND WILL TRANSITION TRADING TO THE OTCQX MARKET - PR Newswire
Marpai director Dendy sells over $100k in company stock - Investing.com
Marpai Inc Stock (MRAI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.48%
0.59%
Cap:
|
Volume (24h):